SCHEMBL8735920

SCHEMBL8735920

CCCCCNCc1ccc(N2CCCC2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 1/20 0.60
HRH3 Q9Y5N1 1/20 0.60
SMN1; SMN2 Q16637 1/20 0.57
CYP1A2 P05177 1/20 0.55
CYP2D6 P10635 1/20 0.55
CYP2C19 P33261 1/20 0.55
LMNA P02545 1/20 0.54
GAA P10253 3/20 0.51
ALDH1A1 P00352 3/20 0.51
HSD17B10 Q99714 1/20 0.51
OPRM1 P35372 1/20 0.48
OPRD1 P41143 1/20 0.48
OPRK1 P41145 1/20 0.48
ALOX15 P16050 2/20 0.48
KDM4E B2RXH2 1/20 0.48
MEN1 O00255 1/20 0.48
APP P05067 1/20 0.48
MAPT P10636 1/20 0.48
ALOX12 P18054 1/20 0.48
MAPK1 P28482 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11922717 0.95 HRH4 (0.53) HRH4HRH3SMN1; SMN2CYP1A2CYP2D6
SCHEMBL17832850 0.92 CXCR4 (0.49) HRH4HRH3GAAALDH1A1ALOX15
SCHEMBL16812990 0.90 CHRM2 (0.50) HRH4HRH3GAAALDH1A1ALOX15
SCHEMBL16812995 0.89 CXCR4 (0.49) SMN1; SMN2GAAALDH1A1HSD17B10ALOX15
SCHEMBL15264995 0.87 ALDH1A1 (0.50) HRH4HRH3SMN1; SMN2LMNAGAA
SCHEMBL18179874 0.85 NCF1 (0.51) SMN1; SMN2LMNAGAAALDH1A1HSD17B10
SCHEMBL16812993 0.84 MAPT (0.56) SMN1; SMN2LMNAGAAALDH1A1HSD17B10
SCHEMBL18179876 0.83 NCF1 (0.50) SMN1; SMN2LMNAGAAALDH1A1HSD17B10
SCHEMBL17832859 0.83 NCF1 (0.50) SMN1; SMN2LMNAGAAALDH1A1HSD17B10
SCHEMBL19750577 0.83 CHRM2 (0.44) HRH4HRH3GAAALDH1A1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120129100-A1 ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, AND RESIST FILM AND PATTERN FORMING METHOD USING THE SAME FUJIFILM CORPORATION (JP) 2012-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120129100-A1 ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, AND RESIST FILM AND PATTERN FORMING METHOD USING THE SAME ACTR8, RAD51, ACTR2 HRH4 1211/4885HRH3 511/4885SMN1; SMN2 2418/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.